
501 - 1000 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
🕒 July 22
Improve your chances of getting an interview by checking your resume score before you apply.

501 - 1000 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Iovance Biotherapeutics, Inc. is pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and attack diverse cancer cells in each patient. The company focuses on T-cell-based immunotherapy, specifically Tumor Infiltrating Lymphocyte (TIL) therapy, which involves reinvigorating a patient’s TILs to fight cancer. Iovance's TIL therapy is being investigated in clinical trials across multiple advanced solid tumor cancers. Additionally, the company is advancing genetically modified TIL therapies and exploring potential applications of PBL (peripheral blood lymphocyte) therapy for blood cancers. As a leader in cell therapy, Iovance owns a state-of-the-art Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary GMP. The company is at the forefront of developing personalized and patient-specific cancer treatments.
• Create and maintain high-impact investor relations and corporate communications materials, including press releases, earnings scripts, Q&A documents, corporate presentations, FAQs, fact sheets, executive biographies, website content, investor decks, templates, and social media content. • Drive internal reviews, approvals, and final deliverables on behalf of the IR and corporate communications team. • Support analyst and institutional investor engagement and help advance investor targeting strategies. • Monitor metrics and analytics for multi-channel external engagement, media coverage, share of voice, company reputation, market activity, analyst sentiment, peer performance, and consensus estimates, to deliver real-time insights for leadership. • Translate key milestones, including earnings, financings, clinical updates, and business developments, into timely, consistent communications for employees, investors, media, and other stakeholders. • Own logistics, timelines, briefing materials, and execution support for events led by the team, including internal town halls, media interviews/roundtables and investor days. • Support media relations by preparing press materials, tracking coverage, and helping build productive relationships with traditional and social media outlets. • Manage agencies and vendors to keep projects moving, on budget, and aligned with investor relations and corporate communications priorities. • Partner with Finance, Legal, Commercial, R&D, Patient Advocacy, and other teams to deliver accurate, consistent, and compliant communications across filings, disclosures, investor materials, the corporate website, internal meetings, and social media. • Improve processes, tools, and workflows to increase the speed, organization, and scalability of the investor relations and corporate communications function. • Lead or support priority investor relations and communications projects as business needs evolve.
• 8+ years of experience in investor relations, external and internal corporate communications, public relations, equity research, investment banking, corporate finance, healthcare communications, or related fields. • Bachelor’s degree required, preferably in Communications, Public Relations, Journalism, Business, Finance, Marketing, Life Sciences, or a related field. • Experience within biotechnology, pharmaceutical, healthcare, agency, or public company environments strongly preferred. • Working knowledge of capital markets, valuation, investor behavior, sell-side research, SEC disclosure requirements, Regulation FD, and public company investor relations practices. • Strong financial and analytical skills, with the ability to turn clinical, scientific, and financial information into clear investment messaging. • Excellent writer and communicator with experience developing persuasive scripts, presentations, executive materials, and stakeholder communications. • Highly organized project manager who can manage multiple priorities, timelines, and stakeholders with speed, accuracy, and attention to detail. • Strong relationship builder with executive presence, sound judgment, and the ability to influence without authority. • Advanced proficiency in PowerPoint, Excel, Outlook, OneDrive, and SharePoint; experience with FactSet, Bloomberg, HubSpot, WordPress, or market-monitoring platforms is a plus. • Professional maturity, discretion, and sound judgment in handling confidential information. • Proactive self-starter who takes ownership, solves problems, and moves work forward with urgency and curiosity.
• Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
Apply Now🕒 July 21
Corporate Communications Manager at Zillow developing communications strategies for litigation and regulatory matters. Collaborating with legal and executive teams to shape media narratives and strategies.
🇺🇸 United States – Remote
💵 $109k - $174k / year
💰 $4.1M Post-IPO Equity on 2012-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🗣️ Communications
🦅 H1B Visa Sponsor
🕒 July 21
Seeking Principal Data Links & Communication Engineer at Applied Research Solutions. Requires tactical data links engineering and experience in software design and development for Air Force systems.
🕒 July 21
Senior SCADA & Communications Engineer managing communications and control systems for renewable energy assets. Collaborating across teams to lead integration and support compliance with industry standards.
🕒 July 20
Field Communications Manager developing communications strategies for Robert Half’s U.S. geography. Supporting field leaders, strategic partnerships, events, and local brand visibility.
🇺🇸 United States – Remote
💵 $77k - $114k / year
⏰ Full Time
🟡 Mid-level
🟠 Senior
🗣️ Communications
🦅 H1B Visa Sponsor
🕒 July 18
Communications Manager advancing Candescent’s fintech PR, media relations, and employee communications. Supporting U.S. media coverage, executive visibility, internal storytelling, and reputation management.